A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer
A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer
Recruiting · NCT07253142 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-07-21 | NCT07253142 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Henlius Biotech | 58 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital of Guangzhou Medical University | Guangzhou | China | 2 |
| Cangzhou People's Hospital | Cangzhou | China | 3 |
| Fujian Cancer Hospital | Fu'zhou | China | 1 |
| Harbin Medical University Cancer Hospital | Harbin | China | 51 |
| Hubei Cancer Hospital | Wuha | China | 2 |
| Shanghai Chest Hospital | Shanghai | China | 31 |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou | China | 21 |
| The First Affiliated Hospital of Xinxiang Medical University | Xinxiang | China | 16 |
| The People's Hospital of Guangxi Zhuangzu Autonomous Region | Nanning | China | 1 |
| The Second Hospital of Anhui Medical University | Hefei | China | 21 |